James M. Bogenberger

As a former American Cancer Society Postdoctoral Fellow and former Research Associate and Assistant Professor of Medicine and Molecular Medicine at Mayo Clinic, James is a multidisciplinary-trained translational precision oncology researcher with therapeutics development experience ranging from functional genomics target identification to clinical correlative studies and collaborative work spanning multiple productive academic and industry relationships involving preclinical and/or clinical development of small molecule, biologic, viral oncolytic, and gene therapy approaches.

James is CSO at Statum Capital Partners’ multi-family office since 2020.